Literature DB >> 32242890

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.

Chirag Bavishi1, Thomas M Maddox2,3, Franz H Messerli4,5,6.   

Abstract

Entities:  

Year:  2020        PMID： 32242890     DOI： 10.1001/jamacardio.2020.1282

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  94 in total

1.  Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

Authors:  Neil Mehta; Ankur Kalra; Amy S Nowacki; Scott Anjewierden; Zheyi Han; Pavan Bhat; Andres E Carmona-Rubio; Miriam Jacob; Gary W Procop; Susan Harrington; Alex Milinovich; Lars G Svensson; Lara Jehi; James B Young; Mina K Chung
Journal:  JAMA Cardiol       Date:  2020-05-05       Impact factor: 14.676

2.  Cardiac considerations in patients with COVID-19.

Authors:  Oscar Calvillo-Argüelles; Heather J Ross
Journal:  CMAJ       Date:  2020-05-01       Impact factor: 8.262

3.  An alternative way of SARS-COV-2 to induce cell stress and elevated DNA damage risk in cardiomyocytes without direct infection.

Authors:  Houqing Zhou; Xiaohu Ren; Yang Yang; Benhong Xu; Yichong Li; Yin Feng; Fang Shisong; Jianjun Liu
Journal:  Immun Inflamm Dis       Date:  2022-07

4.  COVID-19 Pandemic and the Burden of Acute Kidney Injury: The Known and the Unknown.

Authors:  Talha H Imam
Journal:  Perm J       Date:  2020-12

Review 5.  Cardiovascular Impacts on COVID-19 Infected Patients.

Authors:  Somasundaram Raghavan; R Gayathri; Sudhakar Kancharla; Prachetha Kolli; J Ranjitha; Vijayalakshmi Shankar
Journal:  Front Cardiovasc Med       Date:  2021-05-13

Review 6.  The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19.

Authors:  Tatyana A Kuznetsova; Boris G Andryukov; Ilona D Makarenkova; Tatyana S Zaporozhets; Natalya N Besednova; Ludmila N Fedyanina; Sergey P Kryzhanovsky; Mikhail Yu Shchelkanov
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

7.  Antihypertensive medications and COVID-19 diagnosis and mortality: Population-based case-control analysis in the United Kingdom.

Authors:  Emma Rezel-Potts; Abdel Douiri; Phil J Chowienczyk; Martin C Gulliford
Journal:  Br J Clin Pharmacol       Date:  2021-05-10       Impact factor: 3.716

8.  Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).

Authors:  Neil Mehta; Ankur Kalra; Amy S Nowacki; Scott Anjewierden; Zheyi Han; Pavan Bhat; Andres E Carmona-Rubio; Miriam Jacob; Gary W Procop; Susan Harrington; Alex Milinovich; Lars G Svensson; Lara Jehi; James B Young; Mina K Chung
Journal:  JAMA Cardiol       Date:  2020-09-01       Impact factor: 14.676

Review 9.  SARS-CoV-2: Origin, Evolution, and Targeting Inhibition.

Authors:  Shuo Ning; Beiming Yu; Yanfeng Wang; Feng Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

10.  Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.

Authors:  Ikram Omar Osman; Cléa Melenotte; Philippe Brouqui; Matthieu Million; Jean-Christophe Lagier; Philippe Parola; Andréas Stein; Bernard La Scola; Line Meddeb; Jean-Louis Mege; Didier Raoult; Christian A Devaux
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.